Related News
Merck plans 650m yuan pharma factory in Nantong
Online Edition
PHARMACEUTICAL giant Merck announced a 650 million yuan (US$107 million) investment in a new drug manufacturing facility in Nantong, Jiangsu Province.
“The investment reflects Merck’s long-term commitment to China, where our group has been present for 80 years,” said Belen Garijo, president and CEO of Merck Serono, the biopharmaceutical division of Merck.
The new facility will focus on bulk production and packaging of Merck’s leading brands for the treatment of diabetes, cardiovascular diseases and thyroid disorders.
The construction, which start in 2014, will be completed in 2016.
The new facility will become Merck Serono’s second largest pharmaceutical manufacturing site in the world, the company said.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
